We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

The centre for entrepreneurial maturation

The third foundational entity of IMS, Inedis (Innovation in entrepreneurship in drug discovery), proposes actions to structure and accompany the creation of companies emerging from IMS programmes or partner teams. Inedis’s action consists first of all in ensuring a post-maturation stage by structuring and hosting (“open-lab” actions) the operational teams for companies emerging from IMS.

Tailored mentoring

Inedis will mentor companies in their early stages by relying on existing structures (SEMIA, SATT, Biovalley France) and on their committee of external experts and a network of entrepreneurs. The committee will play an active role in constructing Inedis’s mentoring plan, its business model, and the process of identifying key candidates for recruitment to these future IMS companies.

Support Inedis and its start-ups

The young companies emerging from public research need equity capital to transform their technological projects into a business model. Your support is essential if the start-ups are to continue the pre-clinical development of their therapeutic innovation and to develop novel drugs for tomorrow.
Discover the charitable fund to assist start-ups